1. Home /
  2. Drug Approvals

Drug Approvals

Decisions at the Local Level Hold the Key to Economic Recovery

Most of the media continues to focus on the national response to the coronavirus.

Good-Bye to March 2020, Retailmageddon, 32% Unemployment? Trading DocuSign

I don't think it would be too much of a stretch to imagine that too many investors, or citizens for that matter, will mind seeing March 2020 head on out of here.

Congress Drags Its Feet as Markets Fall, 30% Unemployment?, 3 Favorite Stocks

St. Louis Fed Pres. James Bullard sees unemployment possibly hitting 30%, while GDP could ultimately contract 50%.

Mild Good News as Japanese Flu Drug Shows Promise in Mild Covid-19 Cases

Fujifilm Holdings has a promising drug that seems to work in improving the outcome for coronavirus patients in China and Japan, though Avigan is a treatment not a cure.

The Magic Mice of Regeneron

I am pretty well covered in my 'virus group'. I could definitely see bringing a few shares of REGN on board the next time the algorithms include that name in a broad selloff. Not before.

I Have More Hope for Eli Lilly's Research Partnership Than Its Charts

LLY is entering into a new partnership with AbCellera Biologics in an attempt to develop an antibody for Covid-19.

4 Biotech Stocks I'm Targeting Now

I've stayed primarily to those names that have plenty of cash on the balance sheet and should be just fine once saner heads prevail.

Will Gilead Sciences Remdesivir Help Arrest the Coronavirus?

Right now, GILD holds a strictly defensive spot among my holdings.

Moderna Could Spike Much Higher as the Pandemic Story Plays Out

Hot money will be attracted to stocks that show promise in dealing with the coronavirus.

Gilead Gets Some Serious Play

I wouldn't be a buyer of Gilead on the coronavirus news, I'd be a buyer because the yield and chart look pretty darn good.